These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31481360)
21. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Wide K; Winbladh B; Källén B Acta Paediatr; 2004 Feb; 93(2):174-6. PubMed ID: 15046269 [TBL] [Abstract][Full Text] [Related]
22. Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France. Coste J; Blotiere PO; Miranda S; Mikaeloff Y; Peyre H; Ramus F; Zureik M; Weill A; Dray-Spira R Sci Rep; 2020 Oct; 10(1):17362. PubMed ID: 33093466 [TBL] [Abstract][Full Text] [Related]
23. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074 [TBL] [Abstract][Full Text] [Related]
24. Prenatal exposure to antiepileptic drugs and use of primary healthcare during childhood: a population-based cohort study in Denmark. Würtz AM; Rytter D; Vestergaard CH; Christensen J; Vestergaard M; Bech BH BMJ Open; 2017 Jan; 7(1):e012836. PubMed ID: 28069620 [TBL] [Abstract][Full Text] [Related]
25. Fetal antiepileptic drug exposure and cognitive outcomes. Bromley RL; Baker GA Seizure; 2017 Jan; 44():225-231. PubMed ID: 27784632 [TBL] [Abstract][Full Text] [Related]
26. A clinical study of 57 children with fetal anticonvulsant syndromes. Moore SJ; Turnpenny P; Quinn A; Glover S; Lloyd DJ; Montgomery T; Dean JC J Med Genet; 2000 Jul; 37(7):489-97. PubMed ID: 10882750 [TBL] [Abstract][Full Text] [Related]
27. Prenatal valproate exposure and adverse neurodevelopmental outcomes: Does sex matter? Honybun E; Thwaites R; Malpas CB; Rayner G; Anderson A; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE; Perucca P Epilepsia; 2021 Mar; 62(3):709-719. PubMed ID: 33547648 [TBL] [Abstract][Full Text] [Related]
28. Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model. Wen X; Hartzema A; Delaney JA; Brumback B; Liu X; Egerman R; Roth J; Segal R; Meador KJ BMC Pregnancy Childbirth; 2017 Jan; 17(1):10. PubMed ID: 28061833 [TBL] [Abstract][Full Text] [Related]
29. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. Dean JC; Hailey H; Moore SJ; Lloyd DJ; Turnpenny PD; Little J J Med Genet; 2002 Apr; 39(4):251-9. PubMed ID: 11950853 [TBL] [Abstract][Full Text] [Related]
30. Behavioral characteristics and cognitive development among school age children born to women with epilepsy. Güveli BT; Gürses C; Ataklı D; Akça Kalem Ş; Dirican A; Bebek N; Baykan B; Gökyiğit A Neurol Res; 2015 Apr; 37(4):295-300. PubMed ID: 25310353 [TBL] [Abstract][Full Text] [Related]
31. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. Bromley RL; Mawer GE; Briggs M; Cheyne C; Clayton-Smith J; García-Fiñana M; Kneen R; Lucas SB; Shallcross R; Baker GA; J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):637-43. PubMed ID: 23370617 [TBL] [Abstract][Full Text] [Related]
32. In utero antiepileptic drug exposure: fetal death and malformations. Meador KJ; Baker GA; Finnell RH; Kalayjian LA; Liporace JD; Loring DW; Mawer G; Pennell PB; Smith JC; Wolff MC; Neurology; 2006 Aug; 67(3):407-12. PubMed ID: 16894099 [TBL] [Abstract][Full Text] [Related]
33. Early cognitive development in children born to women with epilepsy: a prospective report. Bromley RL; Mawer G; Love J; Kelly J; Purdy L; McEwan L; Briggs M; Clayton-Smith J; Shi X; Baker GA; Epilepsia; 2010 Oct; 51(10):2058-65. PubMed ID: 20633039 [TBL] [Abstract][Full Text] [Related]
34. Normal intelligence in children with prenatal exposure to carbamazepine. Gaily E; Kantola-Sorsa E; Hiilesmaa V; Isoaho M; Matila R; Kotila M; Nylund T; Bardy A; Kaaja E; Granström ML Neurology; 2004 Jan; 62(1):28-32. PubMed ID: 14718692 [TBL] [Abstract][Full Text] [Related]
35. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385 [TBL] [Abstract][Full Text] [Related]
36. Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias. Nicolai J; Vles JS; Aldenkamp AP J Neurol Sci; 2008 Aug; 271(1-2):1-14. PubMed ID: 18479711 [TBL] [Abstract][Full Text] [Related]
37. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Baker GA; Bromley RL; Briggs M; Cheyne CP; Cohen MJ; García-Fiñana M; Gummery A; Kneen R; Loring DW; Mawer G; Meador KJ; Shallcross R; Clayton-Smith J; Neurology; 2015 Jan; 84(4):382-90. PubMed ID: 25540307 [TBL] [Abstract][Full Text] [Related]
38. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Meador KJ; Baker GA; Browning N; Cohen MJ; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW; Lancet Neurol; 2013 Mar; 12(3):244-52. PubMed ID: 23352199 [TBL] [Abstract][Full Text] [Related]
39. Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children. Elkjær LS; Bech BH; Sun Y; Laursen TM; Christensen J JAMA Neurol; 2018 Jun; 75(6):663-671. PubMed ID: 29459981 [TBL] [Abstract][Full Text] [Related]
40. Child development following in utero exposure: levetiracetam vs sodium valproate. Shallcross R; Bromley RL; Irwin B; Bonnett LJ; Morrow J; Baker GA; ; Neurology; 2011 Jan; 76(4):383-9. PubMed ID: 21263139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]